Study Digs into Patient Access to Electronic Health Information
Findings suggest that participants nationwide who were offered and accessed their online medical record has more than doubled in the past eight years, but racial and ethnic disparities continue.
Open Access Forum Analyzes COVID-19 Stem Cell and Exosome Therapies
Stem Cell Reports takes a look at DTC online advertising claims that these are ‘immune boosters.’
Japan Shifts Toward Environmentally Friendly Pharma Practices
JMA Journal report describes how businesses in this Asian-Pacific nation are employing various strategies to reduce GHG emissions.
Access Insights 2023: Price Transparency Data in Pharma
Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.
Access Insights 2023: A View from DC
Conference presentation explores groundbreaking topics impacting the pharma industry.
Access Insights 2023: Biosimilars, Specialty Generics’ Impact on Sites of Care
Session explores how on-market products have done, and what to expect from new biosimilars.
Access Insights 2023: Fight for the Dollar
Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle.
Report Explores Ways to Finance, Repurpose Rare Disease Drugs
Study describes how biotech startups can avoid competing with large pharma companies for financing.
Analysis Shows BRICS Nations Are Making Strides in Vaccine Production
Determination will affect future vaccine cost and accessibility, including in developing countries.
Implementing Sustainable Business Practices
Raphael Chin Fo Sieeuw offers his insight on how to address the sector’s most prominent issues, including how to limit the industry’s carbon footprint.
LogiPharma USA 2023: Women Leaders in Supply Chain
The panel digs deeper into the challenges that women in the life sciences sector face.
LogiPharma USA 2023: Impactful Roundtable Discussions
Conference hosts roundtable chats, with topics ranging from data-driven decision making to cold chain logistics.
LogiPharma USA 2023: Making a List and Checking It Twice
LogiPharma session reminds attendees of what to review, as far as DSCSA compliance is concerned.
Protecting the Pharma Supply Chain
How the links of the supply chain are fighting to preserve quality service, even against factors that may be out of their hands.
All About the Journey
A reflection on my time with Pharma Commerce thus far, and a plan of action for moving the brand forward.
Drilling Down On Distribution
Pharma Commerce converges on Nation's Capital for HDA Traceability Seminar.
Supply Chain Safeguards
Jason Cook uncovers ways in which pharma companies can plan for weather-related challenges that may arise.
HDA 2023 Traceability Seminar: A Status Update
Stakeholders uncover the obstacles surrounding the industry onboarding process.
HDA 2023 Traceability Seminar: DSCSA Roundtable Discussions
Attendees meet to discuss operational issues related to traceability implementation.
HDA 2023 Traceability Seminar: DSCSA Areas of Improvement
Session offers information on industry readiness, plus an overview of a phase implementation recommendation.
HDA 2023 Traceability Seminar: An FDA DSCSA Overview
Event’s first session aims to analyze the legislation’s implementation, as FDA enforcement is delayed until November 2024.
ESG Evolution
In this PC Podcast episode, Susanne Katus discusses the increasing number of regulations impacting both pharma and biotech companies.
Collaboration at the Forefront
As Pharma Commerce continues to increase its conference exposure, it all could not have been possible without the help of colleagues.
The Voyage to Beantown
Pharma Commerce team attends DIA's Annual Meeting for the first time.
Addressing Revenue Leakage
Micah Litow, Kalderos’ president and COO, discusses the importance of identifying and resolving noncompliant discount requests, along with addressing the gross-to-net gap for drug manufacturers.
DIA 2023: The Future of Biosimilars, Interchangeables
Panel explores challenges that could affect their development.
DIA 2023: The Impact of the IRA
Session offers a look into the Inflation Reduction Act’s impact on market conditions.
DIA 2023: Solving the Drug Pricing Problem
Session explores practicality of models for selling low-cost drugs.
DSCSA: A Fast-Approaching Deadline
The legislation’s deadline for compliance is knocking on the door. Pharma Commerce offers a synopsis of how the Drug Supply Chain Security Act has progressed over the past decade.
The DSCSA Overview
How these sets of requirements were developed, and the future outlook on track-and-trace over the next decade.